Maasumeh Sabbaghian, MD
Surgery · Crowley, LANPI 1629220900
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (47.7%), education and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 98.7% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $8,343 and has fallen 98.2% since, to $149 in 2025.
Across 29 payments — averaging $577.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$17K
- Dilon Technologies, Inc.$109
- Conmed Corporation$51
- Pacira Pharmaceuticals Incorporated$24
- W. L. Gore & Associates, Inc.$19
- Eisai Inc.$12
What the payments were for
- Speaking & faculty fees$8,00048%
- Travel & lodging$6424%
- Food & beverage$1,1137%
- Education$7,00042%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 23 | $16,539 |
| Dilon Technologies, Inc. | 1 | $109 |
| Conmed Corporation | 2 | $51 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| W. L. Gore & Associates, Inc. | 1 | $19 |
| Eisai Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$8,010
- DAVINCI XI$8,000
- HemoBlast Bellows$109
How this compares
$16,754 in reported general payments places this provider in the 85th percentile of 381 surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CholestyramineCholestyramine (With Sugar) | 18 | $1,539 |
| Pantoprazole Sodium | 113 | $915 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 14 | $249 |
| Doxycycline Hyclate | 25 | $198 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 25 | $182 |
| Oxycodone Hcl | 63 | $153 |
| Ciprofloxacin Hcl | 11 | $65 |
Paid to pharmacies, not to this prescriber.
Other surgery in Crowley
- John TaborBaton Rouge$567K
- Carlos GalvaniNew Orleans$352K
- Mark HausmannBaton Rouge$250K
- Joseph BuellNew Orleans$186K
- Daryl MarxBaton Rouge$157K
- Matias NautsLake Charles$112K
- Tracee ShortBaton Rouge$108K
- Kamel BraktaShreveport$95K
- Kerry ThibodeauxOpelousas$84K
- Michael CookNew Orleans$84K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.